EZ2
LIVE

Serial Number

79298192

Owner

QIAGEN GMBH

Attorney

G MATHEW LOMBARD

Filing Date

Aug 17, 2020

Add to watchlist:

No watchlists yet
View on USPTO

EZ2 Trademark

Serial Number: 79298192 • Registration: 6822927

EZ2 is a trademark filed by QIAGEN GMBH on August 17, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

QIAGEN GMBH (211 trademarks)

HILDEN D-4010 , DE

Entity Type: 03

Trademark Details

Filing Date

August 17, 2020

Registration Date

August 23, 2022

Published for Opposition

June 7, 2022

Goods & Services

Scientific apparatus, instruments and equipment, namely, sample preparation devices for isolation of nucleic acids and proteins for research, development and examination purposes; scientific apparatus, instruments and laboratory equipment, namely, thermocyclers and automated sample-processing platforms, not for medical use, for marking, separation, isolation, purification, amplification and analysis of biopolymers, in particular nucleic acids, proteins, macro molecules and biologically active substances, in particular nucleic acids from biological and biochemical sample material; chromatography columns for laboratory use; sample preparation instruments for isolation of nucleic acid or proteins and spare parts and add-ons, namely, laboratory pipettes, laboratory pipette tips, laboratory pipette tip holders; laboratory equipment, namely, magnetic particles, thermocyclers for the purpose of performing polymerase chain reactions, homogenizers to homogenize samples for subsequent isolation of nucleic acids or proteins, vacuum valves for the purpose of permitting the operation of laboratory processes under subatmospheric pressure

Diagnostic agents and preparations for medical purposes; diagnostic preparations for medical and veterinary medical purposes, namely, nucleic acids, enzymes, polymerases, reagents for staining or marking, buffers, aqueous and non-aqueous solutions of alcohols and salts, distilled or purified water, silica and magnetic particles; kits comprising diagnostic preparations for medical and veterinary medical diagnostic purposes for the preparation of samples, the modification and manipulation of samples and for marking, separation, isolation, purification, reproduction and analysis of biopolymers, namely, nucleic acids, enzymes, proteins, macromolecules and biologically active substances in the nature of nucleic acids from biological or biochemical sample materials; reagent kits comprising essential diagnostic reagents and assays for medical and veterinary diagnostic purposes, namely, chemical, biochemical and biotechnological preparations for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic preparations for medical and veterinary purposes for marking, separation, isolation, purification, amplification and analysis of biopolymers, namely, enzymes, proteins, macromolecules and biologically active substances in the nature of nucleic acids from biochemical and biotechnological sample materials

Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, nucleic acids, enzymes, polymerases, reagents for staining or marking, buffers, aqueous and non-aqueous solutions of alcohols and salts, distilled or purified water, silica-coated particles in liquid form; magnetic particles in liquid form; reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells, as well as for marking, separation, isolation, purification, amplification and analysis of biopolymers, in particular nucleic acids, enzymes, proteins, macro molecules and biologically active substances, in particular nucleic acids from biological and biochemical sample material; reagent kits comprising chemical, biochemical and biotechnological products, other than for medical or veterinary use, for sample preparation, purification, lysis, modification and manipulation of cells, as well as for marking, separation, isolation, purification, amplification and analysis of biopolymers, namely, nucleic acids, enzymes, proteins, macro molecules and biologically active materials

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 21, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 30, 2022 FICS
FINAL DISPOSITION PROCESSED
Nov 30, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 23, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 23, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 23, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 7, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 7, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 18, 2022 NONP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 9, 2022 OPNX
ELECTRONIC RECORD REVIEW COMPLETE
Apr 29, 2022 FIXD
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 20, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 20, 2022 OPNR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Apr 1, 2022 ERRR
ASSIGNED TO LIE
Mar 27, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 25, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 24, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 24, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 24, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 28, 2021 GNRN
NON-FINAL ACTION E-MAILED
Oct 28, 2021 GNRT
NON-FINAL ACTION WRITTEN
Oct 28, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 5, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 4, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 4, 2021 TROA
REFUSAL PROCESSED BY IB
Feb 21, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 4, 2021 RFCS
REFUSAL PROCESSED BY MPU
Feb 4, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 22, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jan 21, 2021 CNRT
ASSIGNED TO EXAMINER
Dec 12, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 24, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 20, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 19, 2020 REPR